NM-301 (Helixmith)

N/A

Report date: 2025/01/26 17:30:27

Base Information

Drug NameNM-301 (Helixmith)
Drug Alias NameHGF gene therapy (Helixmith)
ClassificationBiologics
Mechanisms of ActionHGF gene transference
TargetsHepatocyte growth factor
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelixmith Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHelixmith Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A